{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:02:07Z","timestamp":1768734127631,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.diabet.2022.101377","type":"journal-article","created":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T15:56:00Z","timestamp":1658073360000},"page":"101377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"48","author":[{"given":"Xinxia","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingfeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huandong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7341-4368","authenticated-orcid":false,"given":"Hongmei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.diabet.2022.101377_bib0001","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabet.2022.101377_bib0002","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with Nonalcoholic Fatty Liver Disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabet.2022.101377_bib0003","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.diabet.2022.101377_bib0004","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.diabet.2022.101377_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.diabet.2022.101377_bib0006","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstr\u00f6m","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.diabet.2022.101377_bib0007","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.diabet.2022.101377_bib0008","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.diabet.2022.101377_bib0009","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4158\/EP-2019-0342","article-title":"Impact of type 2 diabetes on nonalcoholic steatohepatitis and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"26","author":"Bian","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.diabet.2022.101377_bib0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2337\/diacare.22.5.756","article-title":"Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study","volume":"22","author":"De Marco","year":"1999","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.diabet.2022.101377_bib0011","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.diabet.2022.101377_bib0012","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13300-016-0154-2","article-title":"The Economic Burden of Post-prandial Hyperglycemia (PPH) among people with type 1 and type 2 diabetes in three countries","volume":"7","author":"Brod","year":"2016","journal-title":"Diabetes Ther"},{"issue":"14","key":"10.1016\/j.diabet.2022.101377_bib0013","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.diabet.2022.101377_bib0014","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10654-010-9525-6","article-title":"The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design","volume":"25","author":"Gao","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.diabet.2022.101377_bib0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10654-016-0219-6","article-title":"The prevalence of multiple non-communicable diseases among middle-aged and elderly people: the Shanghai Changfeng Study","volume":"32","author":"Lin","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"10.1016\/j.diabet.2022.101377_bib0016","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10654-019-00543-0","article-title":"The major causes and risk factors of total and cause-specific mortality during 5.4-year follow-up: the Shanghai Changfeng Study","volume":"34","author":"Wu","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.diabet.2022.101377_bib0017","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.diabet.2022.101377_bib0018","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Utility and appropriateness of the fatty liver inhibition of progression (FILP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease","volume":"60","author":"Bedossa","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.diabet.2022.101377_bib0019","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.27981","article-title":"Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study","volume":"63","author":"Koehler","year":"2016","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.diabet.2022.101377_bib0020","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00535-013-0911-1","article-title":"Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients","volume":"49","author":"Nakahara","year":"2014","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.diabet.2022.101377_bib0021","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.25772","article-title":"Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.diabet.2022.101377_bib0022","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.cgh.2009.06.007","article-title":"Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Hossain","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.diabet.2022.101377_bib0023","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2337\/diacare.22.5.756","article-title":"Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study","volume":"22","author":"De Marco","year":"1999","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabet.2022.101377_bib0024","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbrc.2004.01.116","article-title":"Acarbose attenuates experimental non-alcoholic steatohepatitis","volume":"315","author":"Lieber","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.diabet.2022.101377_bib0025","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s00535-017-1331-4","article-title":"Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model","volume":"52","author":"Kishida","year":"2017","journal-title":"J Gastroenterol"},{"issue":"10019","key":"10.1016\/j.diabet.2022.101377_bib0026","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.diabet.2022.101377_bib0027","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A Placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"issue":"65","key":"10.1016\/j.diabet.2022.101377_bib0028","first-page":"1338","article-title":"Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes","volume":"52","author":"Morita","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.diabet.2022.101377_bib0029","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diabetes.53.3.701","article-title":"Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment","volume":"53","author":"Ceriello","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2022.101377_bib0030","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/01.CIR.0000165070.46111.9F","article-title":"Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients","volume":"111","author":"Ceriello","year":"2005","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.diabet.2022.101377_bib0031","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2337\/dc18-1390","article-title":"Predictive value of fasting glucose, postload glucose, and hemoglobin A 1c on risk of diabetes and complications in Chinese adults","volume":"42","author":"Lu","year":"2019","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabet.2022.101377_bib0032","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0041-1730927","article-title":"Insights into nonalcoholic fatty-liver disease heterogeneity","volume":"41","author":"Arrese","year":"2021","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.diabet.2022.101377_bib0033","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13293-018-0205-7","article-title":"Tissue-specific pathways and networks underlying sexual dimorphism in non-alcoholic fatty liver disease","volume":"9","author":"Kurt","year":"2018","journal-title":"Biol Sex Differ"},{"issue":"4","key":"10.1016\/j.diabet.2022.101377_bib0034","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.diabet.2022.101377_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2016.07.034","article-title":"Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis","volume":"15","author":"Yang","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.diabet.2022.101377_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.diabet.2022.101377_bib0037","article-title":"Impact of type 2 diabetes on the accuracy of noninvasive tests of liver fibrosis with resulting clinical implications","volume":"11","author":"Boursier","year":"2022","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363622000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363622000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:58:43Z","timestamp":1761130723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363622000593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1262363622000593"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2022.101377","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2022.101377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101377"}}